The Iliac/SFA/Popliteal Center

Filter Your Results




Treating Peripheral Artery Disease in the Popliteal Artery: DA + DCB Versus DCB Alone

Konstantinos Stavroulakis, MD

October 2017—The popliteal artery is a known area of high mechanical stress and dynamic force that has been associated with accelerated restenosis and high rates of stent fracture and occl…

Case Study: Complex Long Lesion Intervention With the Lutonix® 035 Drug-Coated Balloon

Robert E. Beasley, MD

October 2017—Choosing the right DCB is paramount to avoiding complications when patients present with nonhealing wounds and single-vessel runoff.

The State of Peripheral Drug‑Eluting Technologies

Michael R. Jaff, DO

September 2017— When comparing the myriad options available for the treatment of patients with peripheral artery disease (PAD) today compared to just 1 decade ago, it is a testimony to ph…

Interim Results From the Muenster Postmarket All-Comers Registry

Theodosios Bisdas, MD, PhD

September 2017—A look at the latest data on use of the Eluvia drug-eluting stent in challenging SFA lesions.

Twelve-Month Results From the RANGER-SFA Trial

With Dierk Scheinert, MD

September 2017—What these findings tell us about the safety and efficacy of the Ranger drug-coated balloon.

Experience With Atherectomy and DCBs

Ulrich Sunderdiek, MD, PhD

September 2017—The merits of a two-part approach in the SFA and popliteal artery.

Economic Analysis Supporting the Use of Drug-Eluting Technologies in the Femoropopliteal Artery

Konstantinos Katsanos, MSc, MD, PhD, EBIR

September 2017—These evolving modern therapies are showing promise in reducing health care costs while offering better outcomes.

Clinical Benefit of Long-Length Drug-Coated Balloons

Gunnar Tepe, MD

September 2017—The anatomic factors that make longer DCBs the ideal choice for treating longer, more difficult lesions.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.